1. Home
  2. SIG vs VKTX Comparison

SIG vs VKTX Comparison

Compare SIG & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIG
  • VKTX
  • Stock Information
  • Founded
  • SIG 1950
  • VKTX 2012
  • Country
  • SIG Bermuda
  • VKTX United States
  • Employees
  • SIG N/A
  • VKTX N/A
  • Industry
  • SIG Consumer Specialties
  • VKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SIG Consumer Discretionary
  • VKTX Health Care
  • Exchange
  • SIG Nasdaq
  • VKTX Nasdaq
  • Market Cap
  • SIG 3.1B
  • VKTX 3.5B
  • IPO Year
  • SIG N/A
  • VKTX 2015
  • Fundamental
  • Price
  • SIG $90.50
  • VKTX $26.53
  • Analyst Decision
  • SIG Buy
  • VKTX Strong Buy
  • Analyst Count
  • SIG 6
  • VKTX 13
  • Target Price
  • SIG $100.67
  • VKTX $86.92
  • AVG Volume (30 Days)
  • SIG 1.1M
  • VKTX 9.9M
  • Earning Date
  • SIG 09-02-2025
  • VKTX 10-22-2025
  • Dividend Yield
  • SIG 1.42%
  • VKTX N/A
  • EPS Growth
  • SIG N/A
  • VKTX N/A
  • EPS
  • SIG 3.04
  • VKTX N/A
  • Revenue
  • SIG $6,778,700,000.00
  • VKTX N/A
  • Revenue This Year
  • SIG $1.41
  • VKTX N/A
  • Revenue Next Year
  • SIG $1.07
  • VKTX N/A
  • P/E Ratio
  • SIG $29.65
  • VKTX N/A
  • Revenue Growth
  • SIG N/A
  • VKTX N/A
  • 52 Week Low
  • SIG $45.55
  • VKTX $18.92
  • 52 Week High
  • SIG $106.28
  • VKTX $81.73
  • Technical
  • Relative Strength Index (RSI)
  • SIG 60.38
  • VKTX 39.45
  • Support Level
  • SIG $85.31
  • VKTX $26.13
  • Resistance Level
  • SIG $91.85
  • VKTX $28.26
  • Average True Range (ATR)
  • SIG 3.72
  • VKTX 1.64
  • MACD
  • SIG 0.62
  • VKTX -0.53
  • Stochastic Oscillator
  • SIG 78.78
  • VKTX 17.46

About SIG Signet Jewelers Limited

Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: